lactic acid has been researched along with Vitreoretinopathy, Proliferative in 6 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Vitreoretinopathy, Proliferative: Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of sustained-release cis-4-hydroxyproline (CHP), a proline analog that inhibits collagen secretion, on experimental proliferative vitreoretinopathy (PVR) in rabbits." | 7.71 | Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits. ( Honda, Y; Kimura, H; Miyamoto, H; Ogura, Y; Tabata, Y; Yasukawa, T, 2002) |
| "To evaluate the efficacy of sustained-release cis-4-hydroxyproline (CHP), a proline analog that inhibits collagen secretion, on experimental proliferative vitreoretinopathy (PVR) in rabbits." | 3.71 | Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits. ( Honda, Y; Kimura, H; Miyamoto, H; Ogura, Y; Tabata, Y; Yasukawa, T, 2002) |
| "The plugs are effective for treating vitreoretinal diseases such as proliferative vitreoretinopathy." | 2.41 | Biodegradable scleral plugs for vitreoretinal drug delivery. ( Kimura, H; Ogura, Y; Tabata, Y; Yasukawa, T, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, X | 1 |
| Wei, J | 1 |
| Ma, P | 1 |
| Mu, H | 1 |
| Wang, A | 1 |
| Zhang, L | 1 |
| Wu, Z | 1 |
| Sun, K | 1 |
| Yasukawa, T | 2 |
| Kimura, H | 2 |
| Tabata, Y | 2 |
| Miyamoto, H | 1 |
| Honda, Y | 2 |
| Ogura, Y | 3 |
| Dong, X | 1 |
| Chen, N | 1 |
| Xie, L | 1 |
| Wang, S | 1 |
| Hashizoe, M | 1 |
| Takanashi, T | 1 |
| Kunou, N | 1 |
| Ikada, Y | 1 |
| Herrero-Vanrell, R | 1 |
| Refojo, MF | 1 |
1 review available for lactic acid and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Biodegradable scleral plugs for vitreoretinal drug delivery.
Topics: Animals; Biodegradation, Environmental; Cytomegalovirus Retinitis; Drug Delivery Systems; Eye Diseas | 2001 |
5 other studies available for lactic acid and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Preparation and evaluation of a novel biodegradable long-acting intravitreal implant containing ligustrazine for the treatment of proliferative vitreoretinopathy.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Delayed-Action Preparations; Disease Models, | 2015 |
Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Chromatography, High Pressure Liquid; Delayed | 2002 |
Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal drug delivery system of all-trans retinoic acid.
Topics: Absorbable Implants; Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Drug Del | 2006 |
Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy.
Topics: Animals; Biodegradation, Environmental; Cell Division; Chromatography, High Pressure Liquid; Delayed | 1995 |
Biodegradable microspheres for vitreoretinal drug delivery.
Topics: Animals; Biodegradation, Environmental; Drug Delivery Systems; Eye Diseases; Humans; Lactic Acid; Mi | 2001 |